AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 69 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $446,000 | -18.9% | 83,572 | 0.0% | 0.60% | -7.7% |
| Q2 2019 | $550,000 | -12.8% | 83,572 | -13.9% | 0.65% | -25.7% |
| Q1 2019 | $631,000 | -20.9% | 97,056 | -17.1% | 0.88% | -18.6% |
| Q4 2018 | $798,000 | -29.4% | 117,056 | -31.3% | 1.08% | +1.8% |
| Q3 2018 | $1,131,000 | +17.9% | 170,356 | 0.0% | 1.06% | +20.5% |
| Q2 2018 | $959,000 | +18.4% | 170,356 | +9.1% | 0.88% | +3.5% |
| Q1 2018 | $810,000 | +14.6% | 156,126 | 0.0% | 0.85% | +17.6% |
| Q4 2017 | $707,000 | -19.4% | 156,126 | +11.6% | 0.72% | -32.8% |
| Q3 2017 | $877,000 | +116.0% | 139,937 | +111.1% | 1.07% | +74.6% |
| Q2 2017 | $406,000 | +23.0% | 66,304 | +47.3% | 0.62% | +34.6% |
| Q1 2017 | $330,000 | – | 45,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |